Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.01 USD | -0.99% | -4.07% | -83.86% |
05-14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
05-10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 140M 190M |
---|---|---|---|---|---|
Net income 2024 * | -109M -148M | Net income 2025 * | -132M -180M | EV / Sales 2024 * | - |
Net cash position 2024 * | 152M 207M | Net cash position 2025 * | 216M 294M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.44
x | P/E ratio 2025 * |
-1.46
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.64% |
Latest transcript on RAPT Therapeutics, Inc.
1 day | -0.99% | ||
1 week | -4.07% | ||
1 month | -50.65% | ||
3 months | -55.35% | ||
6 months | -75.20% | ||
Current year | -83.86% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 15-07-31 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 19-12-01 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 22-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 19-12-03 |
William Rieflin
CHM | Chairman | 64 | 15-04-30 |
Wendye Robbins
BRD | Director/Board Member | 63 | 19-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 234 M€ | +8.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 4.01 | -0.99% | 1,038,471 |
24-05-30 | 4.05 | +2.53% | 583,549 |
24-05-29 | 3.95 | -3.07% | 595,766 |
24-05-28 | 4.075 | -2.51% | 383,018 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.86% | 140M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- RAPT Stock